Prospective evaluation of patients with non‐cirrhotic portal hypertension: A single centre study
Maria Mironova(National Institutes of Health), Theo Heller(National Institutes of Health), David E. Kleiner, Alison Faust(Pennsylvania State University), Ivan J. Fuss(National Institutes of Health), Bernadette Redd(National Institutes of Health Clinical Center), Julian Hercun(National Institutes of Health), Jenna Bergerson, Harish Gopalakrishna(National Institutes of Health), Asif Hitawala(National Institutes of Health), Jaha Norman‐Wheeler(National Institutes of Health), Gracia M. Viana Rodriguez(National Institutes of Health), Shani Scott(National Institutes of Health), Nehna Abdul Majeed(National Institutes of Health), Jacqueline Laurin(Johns Hopkins University), Christopher Koh(National Institutes of Health)
Cited by 12
Related Papers
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
|New England Journal of Medicine|2010|3.3k
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
|The Lancet|2014|2.2k
Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease
|New England Journal of Medicine|2021|1.1k
Early-Onset Stroke and Vasculopathy Associated with Mutations in ADA2
|New England Journal of Medicine|2014|889